» Authors » Qing-Qing Li

Qing-Qing Li

Explore the profile of Qing-Qing Li including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 123
Citations 558
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zheng X, Wu Y, Wu L, Zhang L, Zhang L, Jin Z, et al.
J Pharm Biomed Anal . 2025 Mar; 260:116800. PMID: 40086052
Soy isoflavones exert estrogen-like synergistic or antagonistic effects by binding to estrogen receptors, and potentially impact the function of female reproductive system, but their distribution profile in human remains little...
2.
Qin L, Zhang H, Li Q, Wu T, Cheng S, Wang K, et al.
Theranostics . 2025 Mar; 15(7):3203-3205. PMID: 40083917
[This corrects the article DOI: 10.7150/thno.90322.].
3.
Li Q, Zhang J, Zhu J, Ru X
Zhongguo Gu Shang . 2025 Mar; 38(2):147-51. PMID: 40033614
Objective: To study the relevant factors affecting the occurrence of adjacent vertebral fractures in women with osteoporotic vertebral compression fractures after conservative treatments. Methods: A total of 98 elderly female...
4.
Li Q, Zhang H, Sun G, Han Y, Liu H
Traffic Inj Prev . 2025 Feb; :1-8. PMID: 39983035
Objective: The complex alignment of 2-lane roads results in a higher risk of traffic crashes. This study aims to identify key factors influencing vehicle driving states on curves. Methods: Five...
5.
Li J, Li Q
Huan Jing Ke Xue . 2025 Feb; 46(2):625-635. PMID: 39962645
Given that the Beijing-Tianjin-Hebei Region and its surrounding areas are one of the key areas for air pollution prevention and control in China, testing the impact of air quality on...
6.
Zhang M, Zhang Y, Yu S, Qiao N, Ni X, Liu Q, et al.
Biomed Chromatogr . 2025 Feb; 39(3):e70022. PMID: 39935377
Danatinib, a brand-new compound synthesized in our laboratory for the treatment of acute myeloid leukemia (AML), demonstrates remarkable antitumor activity. However, the pharmacokinetic profile of Danatinib in mice was short...
7.
Wu K, Li Q, Luo X, Wang X, Lai Y, Tian D, et al.
Ann Med . 2025 Jan; 57(1):2453091. PMID: 39834281
Background: Chemoimmunotherapy is the first-line therapy for patients with recurrent or metastatic nasopharyngeal carcinoma (NPC) and is currently the main induction treatment option for patients with locoregionally advanced NPC. However,...
8.
Li Q, Quan X, Wang Z, Qiao N, Ni X, Jing X, et al.
J Med Chem . 2024 Dec; 68(1):108-134. PMID: 39722476
Through catalyzing the transfer of methyl groups onto the guanidinium of arginine, protein arginine methyltransferase 5 (PRMT5) was essential to the cell growth of cancer cells. By utilizing a scaffold...
9.
Wei T, Zhou S, Jing X, Liu J, Sun M, Zhao Z, et al.
J Chem Inf Model . 2024 Dec; 64(24):9528-9550. PMID: 39623285
Developing selective kinase inhibitors remains a formidable challenge in drug discovery because of the highly conserved structural information on adenosine triphosphate (ATP) binding sites across the kinase family. Tailoring docking...
10.
Yang J, Zhang Y, Li Y, Wang Q, Zhang M, Xu Y, et al.
Drug Dev Res . 2024 Nov; 85(8):e70022. PMID: 39569546
The abnormal overexpression of FLT3 kinase is intimately associated with pathogenesis of acute myeloid leukemia (AML), positioning FLT3 inhibitors as pivotal therapeutic agents. Despite the availability of three FDA-approved FLT3...